DK0750616T3 - Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser - Google Patents

Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser

Info

Publication number: DK0750616T3
Authority: DK; Denmark
Prior art keywords: tetrahydro; benzazapine; compounds; acid addition; addition salts
Prior art date: 1994-03-16

Application number

DK95912143T

Other languages

Danish (da)

English (en)

Inventor

Louis Brammer Hansen

Rolf Emil Amsler

Scott Eugene Mcgraw

Original Assignee

Cenes Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-16

Filing date

1995-03-08

Publication date

2001-07-23

1995-03-08 Application filed by Cenes Ltd filed Critical Cenes Ltd

2001-07-23 Application granted granted Critical

2001-07-23 Publication of DK0750616T3 publication Critical patent/DK0750616T3/da

Links

150000003839 salts Chemical class 0.000 title abstract 2
239000002253 acid Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
DIKLCFJDIZFAOM-INIZCTEOSA-N (5s)-5-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)-8-chloro-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol Chemical class C1N(C)CCC2=CC(Cl)=C(O)C=C2[C@H]1C1=CC(Br)=CC2=C1OCC2 DIKLCFJDIZFAOM-INIZCTEOSA-N 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK95912143T 1994-03-16 1995-03-08 Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser DK0750616T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK31194		1994-03-16
PCT/DK1995/000106 WO1995025102A1 (en)	1994-03-16	1995-03-08	Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds

Publications (1)

Publication Number	Publication Date
DK0750616T3 true DK0750616T3 (da)	2001-07-23

Family

ID=8092128

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95912143T DK0750616T3 (da)	1994-03-16	1995-03-08	Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser

Country Status (10)

Country	Link
US (1)	US5658899A (de)
EP (1)	EP0750616B1 (de)
JP (1)	JPH09510222A (de)
AT (1)	ATE201680T1 (de)
AU (1)	AU1945495A (de)
DE (1)	DE69521122T2 (de)
DK (1)	DK0750616T3 (de)
ES (1)	ES2158094T3 (de)
IL (1)	IL112999A0 (de)
WO (1)	WO1995025102A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6410527B1 (en) *	1998-03-02	2002-06-25	Schering Corporation	Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
DE19853487A1 (de)	1998-11-19	2000-05-25	Fumapharm Ag Muri	Verwendung von Dialkylfumaraten
DE10000577A1 (de) *	2000-01-10	2001-07-26	Fumapharm Ag Muri	Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
EP1372634B1 (de)	2001-01-12	2009-11-11	Biogen Idec International GmbH	Verwendung von fumarsäureamiden
UA79248C2 (en) *	2001-11-09	2007-06-11	Janssen Pharmaceutica Nv	Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
CN1674901A (zh) *	2002-08-05	2005-09-28	桑多斯股份公司	新的地氯雷他定半富马酸盐及其多晶型物
PL1663197T3 (pl)	2003-09-09	2008-09-30	Biogen Idec Int Gmbh	Zastosowanie pochodnych kwasu fumarowego do leczenia niewydolności serca oraz astmy
LT2653873T (lt)	2007-02-08	2022-10-10	Biogen Ma Inc.	Kompozicijos ir naudojimas, skirti išsėtinei sklerozei gydyti
KR102578140B1 (ko) *	2011-09-16	2023-09-14	퍼시몬 테크놀로지스 코포레이션	로봇 구동부 및 무선 데이터 커플링
CA2879020C (en)	2012-07-12	2021-02-09	Psyadon Pharmaceuticals, Inc.	Fused benzazepines for treatment of tourette's syndrome
DK3057595T3 (da)	2013-10-18	2020-08-10	Emalex Biosciences Inc	Smeltebenzazepiner til behandling af stammen
KR20240046638A (ko)	2014-01-21	2024-04-09	퍼시몬 테크놀로지스 코포레이션	기판 이송 진공 플랫폼

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5470850A (en) *	1992-02-24	1995-11-28	Novo Nordisk A/S	2,3,4,5-tetrahydro-1H-3-benzazepines
DK23392D0 (da) *	1992-02-24	1992-02-24	Novo Nordisk As	Heterocykliske forbindelser, deres anvendelse og fremstilling

1995
- 1995-03-08 AT AT95912143T patent/ATE201680T1/de not_active IP Right Cessation
- 1995-03-08 ES ES95912143T patent/ES2158094T3/es not_active Expired - Lifetime
- 1995-03-08 JP JP7523785A patent/JPH09510222A/ja active Pending
- 1995-03-08 DE DE69521122T patent/DE69521122T2/de not_active Expired - Lifetime
- 1995-03-08 AU AU19454/95A patent/AU1945495A/en not_active Abandoned
- 1995-03-08 DK DK95912143T patent/DK0750616T3/da active
- 1995-03-08 WO PCT/DK1995/000106 patent/WO1995025102A1/en active IP Right Grant
- 1995-03-08 EP EP95912143A patent/EP0750616B1/de not_active Expired - Lifetime
- 1995-03-14 US US08/404,394 patent/US5658899A/en not_active Expired - Lifetime
- 1995-03-15 IL IL11299995A patent/IL112999A0/xx unknown

Also Published As

Publication number	Publication date
DE69521122T2 (de)	2002-03-07
EP0750616A1 (de)	1997-01-02
EP0750616B1 (de)	2001-05-30
DE69521122D1 (de)	2001-07-05
ES2158094T3 (es)	2001-09-01
ATE201680T1 (de)	2001-06-15
WO1995025102A1 (en)	1995-09-21
US5658899A (en)	1997-08-19
JPH09510222A (ja)	1997-10-14
AU1945495A (en)	1995-10-03
IL112999A0 (en)	1995-06-29

Publication	Publication Date	Title
TR200200579T2 (tr)	2002-12-23	Amino-tirazolpiridin türevleri.
SE9504661D0 (sv)	1995-12-22	New compounds
ITFI910071U1 (it)	1992-12-25	Piastra per osso per la porzione distale dell'omero.
FI963070A (fi)	1996-08-02	Klooripyrimidiinivälituotteita
ATE114113T1 (de)	1994-12-15	Verwendung von droloxifen bei der behandlung von knochenerkrankungen.
TR199901305T2 (xx)	1999-08-23	Calpain-�nleyicileri olarak ketonbenzamidler
TR199700844T1 (xx)	1998-01-21	Pirazolil-Benzoil T�revleri.
FR2663836B1 (fr)	1994-09-23	Implant orthopedique ou dentaire multibloc.
DE69007080D1 (de)	1994-04-07	Orale Hygienezusammensetzung.
DK1100789T3 (da)	2005-05-23	Substituerede benzoylcyclohexandioner
DK0750616T3 (da)	2001-07-23	Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
DK0998287T3 (da)	2003-09-01	Anvendelse af levobupivacain
BR9509975A (pt)	1998-06-09	Formulação farmacêutica
IT8919074A0 (it)	1989-01-12	Composizione per l'igiene orale.
ITMI913465A1 (it)	1993-06-23	Procedimento per la depurazione dell'1, 1, 1-trifluoro-2-fluoroetano
DK0536197T3 (da)	1995-11-13	Ren, krystallinsk form af rifapentine
SE9504662D0 (sv)	1995-12-22	New compounds
DE69936052D1 (de)	2007-06-21	N1 modifizierte glycopeptide
DE60121048D1 (de)	2006-08-03	PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
ITRM910146U1 (it)	1993-01-11	Strumento chirurgico per l'introduzione di protesi peniene.
TR199800958A2 (xx)	1998-12-21	Herbisidal 3,5-Difloropridinleri.
IT9021063A0 (it)	1990-07-25	Sintesi di attivita' anti-hiv, 3h-tiazolo 3,4-a benzimidazoli 1-sostituiti
BR9809286A (pt)	2000-07-04	Processos para redução de fibrinogênio
DE9403721U1 (de)	1994-07-14	Antiseptisches, chirurgisches Druckpflaster
NO981135L (no)	1998-03-13	Syreaddisjonssalter av 2,3,4,5-tetrahydro-1H-3-benzazepinforbindelser